Syros Pharmaceuticals (SYRS)
(Real Time Quote from BATS)
$1.59 USD
-0.03 (-1.55%)
Updated Aug 15, 2024 12:04 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Earnings News For SYRS
-
Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update
-
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
-
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
-
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
-
Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Lags Revenue Estimates
-
Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates
-
Syros Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses Revenue Estimates
-
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Will Syros Pharmaceuticals, Inc. (SYRS) Report Negative Q2 Earnings? What You Should Know
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Will Syros Pharmaceuticals, Inc. (SYRS) Report Negative Q2 Earnings? What You Should Know
-
Syros Pharmaceuticals Inc (SYRS) Reports Q1 Loss, Tops Revenue Estimates